His scientific interests lie mostly in Antibody, Immunology, Immunotherapy, Internal medicine and Molecular biology. His study connects Pharmacokinetics and Antibody. His work on Antigen and Immunopathology as part of general Immunology study is frequently linked to Population, bridging the gap between disciplines.
His research investigates the connection between Immunotherapy and topics such as Pathology that intersect with problems in Metastasis, Urology, Cancer and Breast cancer. His biological study spans a wide range of topics, including Gastroenterology, Endocrinology and Surgery. He combines subjects such as Messenger RNA, Gene expression and Cytolysis with his study of Molecular biology.
His primary areas of investigation include Internal medicine, Immunology, Antibody, Monoclonal antibody and Cancer research. His Internal medicine research includes themes of Gastroenterology, Radioimmunotherapy, Surgery and Oncology. His study focuses on the intersection of Gastroenterology and fields such as Toxicity with connections in the field of Pharmacokinetics.
Many of his research projects under Immunology are closely connected to In patient with In patient, tying the diverse disciplines of science together. His work deals with themes such as Molecular biology, Receptor, Pharmacology and Monocyte, which intersect with Antibody. His Cancer research study combines topics in areas such as Cancer, Breast cancer, Ex vivo, Apoptosis and Poly ADP ribose polymerase.
Albert F. LoBuglio mainly focuses on Cancer research, Breast cancer, Internal medicine, Cancer and Oncology. His Cancer research research integrates issues from Cancer stem cell, Immunology, Pathology, Poly ADP ribose polymerase and Cytotoxicity. His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology and Surgery.
The study incorporates disciplines such as Agonist, Receptor and Basal in addition to Cancer. His work carried out in the field of Oncology brings together such families of science as Chemotherapy, Adjuvant therapy, Regimen, Stage ii and Triple-negative breast cancer. The concepts of his Pharmacology study are interwoven with issues in Cytotoxic T cell, Antibody and Cell growth.
His primary areas of study are Cancer research, Breast cancer, Cancer, Internal medicine and Antibody. His studies deal with areas such as Immunology, Molecular biology, Poly ADP ribose polymerase, Estrogen receptor and Cytotoxicity as well as Cancer research. His Immunology research incorporates themes from Gastroenterology and Cell, CD44.
His Cancer research is multidisciplinary, relying on both Surgery and Homologous recombination. His study brings together the fields of Oncology and Internal medicine. His study in Antibody is interdisciplinary in nature, drawing from both Cell growth, Agonist, Receptor, Genotype and Pharmacology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: